Stem Cell Therapy for Neurodegenerative Diseases
Author(s) -
Jong Zin Yee,
KiWook Oh,
Seung Hyun Kim
Publication year - 2015
Publication title -
hanyang medical reviews
Language(s) - English
Resource type - Journals
eISSN - 2234-4446
pISSN - 1738-429X
DOI - 10.7599/hmr.2015.35.4.229
Subject(s) - stem cell , induced pluripotent stem cell , stem cell therapy , amyotrophic lateral sclerosis , medicine , embryonic stem cell , mesenchymal stem cell , progenitor cell , neural stem cell , disease , cell therapy , neuroscience , pathology , biology , biochemistry , genetics , gene
Neurodegenerative diseases are the hereditary and sporadic conditions which are characterized by progressive neuronal degeneration. Neurodegenerative diseases are emerging as the leading cause of death, disabilities, and a socioeconomic burden due to an increase in life expectancy. There are many neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis, but we have no effective treatments or cures to halt the progression of any of these diseases. Stem cell-based therapy has become the alternative option to treat neurodegenerative diseases. There are several types of stem cells utilized; embryonic stem cells, induced pluripotent stem cells, and adult stem cell (mesenchymal stem cells and neural progenitor cells). In this review, we summarize recent advances in the treatments and the limitations of various stem cell technologies. Especially, we focus on clinical trials of stem cell therapies for major neurodegenerative diseases.This study was supported by grants from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI12C0135)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom